10,11-MD-CPT

N/A

Report date: 2025/06/11 10:17:21
NME

Base Information

Drug Name10,11-MD-CPT
Drug Alias Name10,11-methylenedioxy-20(S)-camptothecin
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCanget BioTekpharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesCanget BioTekpharma LLC
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A